Biology Reference
In-Depth Information
[26] Ertault-Daneshpouy M, Leboeuf C, Lemann M, Bouhidel F, Ades L, Gluckman E, et al.
Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host dis-
ease. Blood 2004;103:4681-4.
[27] Dumler JS, Beschorner WE, Farmer ER, Di Gennaro KA, Saral R, Santos GW. Endothelial-
cell injury in cutaneous acute graft-versus-host disease. Am J Pathol 1989;135:1097-103.
[28] Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, et al. Endothe-
lial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft
versus host disease. Lancet 2002;359:2078-83.
[29] Fleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, et al. Cutaneous
chronic graft-versus-host disease does not have the abnormal endothelial phenotype or
vascular rarefaction characteristic of systemic sclerosis. PLoS One 2009;4:e6203.
[30] Shimura K, Ashihara E, Shimazaki C, Matsunaga S, Taniguchi K, Uchiyama H, et al.
Circulating endothelial progenitor cells decreased in patients with sclerodermatous
chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008;14:426-37.
[31] Luft T, Dietrich S, Falk C, Conzelmann M, Hess M, Benner A, et al. Steroid-refractory
GVHD: T-cell attack within a vulnerable endothelial system. Blood 2011;118:1685-92.
[32] Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. Prevention
of graft versus host disease by inactivation of host antigen-presenting cells. Science
1999;285:412-5.
[33] Hahn I, Klaus A, Maus R, Christman JW, Welte T, Maus UA. Dendritic cell depletion and
repopulation in the lung after irradiation and bone marrow transplantation in mice. Am
J Respir Cell Mol Biol 2011;45:534-41.
[34] Watanabe N, Narita M, Furukawa T, Nakamura T, Yamahira A, Masuko M, et al. Kinet-
ics of pDCs, mDCs, γδT cells and regulatory T cells in association with graft versus host
disease after hematopoietic stem cell transplantation. Int J Lab Hematol 2011;33:378-90.
[35] Kreisel D, Krupnick AS, Gelman AE, Engels FH, Popma SH, Krasinskas AM, et al. Non-
hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an
alternative mechanism of allorecognition. Nat Med 2002;8:233-9.
[36] Limmer A, Ohl J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, et al. Efficient presenta-
tion of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-
specific T-cell tolerance. Nat Med 2000;6:1348-54.
[37] Manes TD, Pober JS. Antigen presentation by human microvascular endothelial cells trig-
gers ICAM-1-dependent transendothelial protrusion by, and fractalkine-dependent tran-
sendothelial migration of, effector memory CD4+ T cells. J Immunol 2008;180:8386-92.
[38] Bolinger B, Krebs P, Tian Y, Engeler D, Scandella E, Miller S, et al. Immunologic igno-
rance of vascular endothelial cells expressing minor histocompatibility antigen. Blood
2008;111:4588-95.
[39] Brent L, Medawar P. Quantitative studies on tissue transplantation immunity. VII. The
normal lymphocyte transfer reaction. Proc R Soc London B Biol Sci 1966;165:281-307.
[40] Streilein JW, Billingham RE. An analysis of the genetic requirements for delayed
cutaneous hypersensitivity reactions to transplantation antigens in mice. J Exp Med
1970;131:409-27.
[41] Sidky YA, Auerbach R. Lymphocyte-induced angiogenesis: a quantitative and sensitive
assay of the graft-vs.-host reaction. J Exp Med 1975;141:1084-100.
[42] Danese S, Sans M, Spencer DM, Beck I, Donate F, Plunkett ML, et al. Angiogenesis block-
ade as a new therapeutic approach to experimental colitis. Gut 2007;56:855-62.
[43] Firestein GS. Starving the synovium: angiogenesis and inflammation in rheumatoid
arthritis. J Clin Invest 1999;103:3-4.
[44] Halin C, Fahrngruber H, Meingassner JG, Bold G, Littlewood-Evans A, Stuetz A, et al.
Inhibition of chronic and acute skin inflammation by treatment with a vascular endo-
thelial growth factor receptor tyrosine kinase inhibitor. Am J Pathol 2008;173:265-77.
[45] Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358:2039-49.
[46] Penack O, Henke E, Suh D, King CG, Smith OM, Na IK, et al. Inhibition of neovascular-
ization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J
Natl Cancer Inst 2010;102:894-908.
[47] Hirst DG, Denekamp J, Hobson B. Proliferation studies of the endothelial and smooth
muscle cells of the mouse mesentery after irradiation. Cell Tissue Kinet 1980;13:91-104.
[48] Runkel S, Hunter N, Milas L. An intradermal assay for quantification and kinetics studies
of tumor angiogenesis in mice. Radiat Res 1991;126:237-43.
[49] Marmaduke DP, Greenson JK, Cunningham I, Herderick EE, Cornhill JF. Gastric vas-
cular ectasia in patients undergoing bone marrow transplantation. Am J Clin Pathol
1994;102:194-8.
[50] Kim DH, Lee NY, Lee MH, Sohn SK. Vascular endothelial growth factor gene polymor-
phisms may predict the risk of acute graft-versus-host disease following allogeneic
transplantation: preventive effect of vascular endothelial growth factor gene on acute
graft-versus-host disease. Biol Blood Marrow Transplant 2008;14:1408-16.
490
Search WWH ::




Custom Search